Based on the results from our current study, it is plausible therefore, that in older persons, declining levels and bioavailability of IGF-I reduce expression of Nrf2, prolonging QTc, and increasing the propensity for malignant arrhythmias. The gene discussed is NFE2L2; the disease is cancer.